- Home
- TEVA vs ACM Comparison
TEVA vs ACM Comparison
Compare TEVA & ACM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- ACM
- Stock Information
- Founded
- TEVA 1901
- ACM 1980
- Country
- TEVA Israel
- ACM United States
- Employees
- TEVA N/A
- ACM N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- ACM Military/Government/Technical
- Sector
- TEVA Health Care
- ACM Consumer Discretionary
- Exchange
- TEVA Nasdaq
- ACM Nasdaq
- Market Cap
- TEVA 19.2B
- ACM 15.4B
- IPO Year
- TEVA N/A
- ACM 2007
- Fundamental
- Price
- TEVA $21.94
- ACM $108.00
- Analyst Decision
- TEVA Buy
- ACM Strong Buy
- Analyst Count
- TEVA 7
- ACM 8
- Target Price
- TEVA $21.00
- ACM $119.38
- AVG Volume (30 Days)
- TEVA 11.9M
- ACM 909.7K
- Earning Date
- TEVA 01-29-2025
- ACM 02-03-2025
- Dividend Yield
- TEVA N/A
- ACM 0.85%
- EPS Growth
- TEVA N/A
- ACM 655.22
- EPS
- TEVA N/A
- ACM 2.95
- Revenue
- TEVA $16,772,000,000.00
- ACM $16,105,498,000.00
- Revenue This Year
- TEVA $4.70
- ACM $6.98
- Revenue Next Year
- TEVA $4.47
- ACM $5.22
- P/E Ratio
- TEVA N/A
- ACM $29.11
- Revenue Growth
- TEVA 9.81
- ACM 12.01
- 52 Week Low
- TEVA $10.34
- ACM $82.23
- 52 Week High
- TEVA $22.17
- ACM $118.56
- Technical
- Relative Strength Index (RSI)
- TEVA 75.93
- ACM 38.31
- Support Level
- TEVA $16.25
- ACM $110.87
- Resistance Level
- TEVA $21.98
- ACM $111.10
- Average True Range (ATR)
- TEVA 0.79
- ACM 1.91
- MACD
- TEVA 0.53
- ACM -1.00
- Stochastic Oscillator
- TEVA 90.58
- ACM 17.06
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About ACM AECOM
Aecom is one of the largest global providers of design, engineering, construction, and management services. It serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $16.1 billion in sales in fiscal 2024.